Helicobacter pylori and bismuth subnitrate
Sodeman, W.A.
American Journal of Gastroenterology 85(9): 1200-1201
1990
ISSN/ISBN: 0002-9270 PMID: 2389738 Document Number: 367558
Document emailed within 1 workday
Related Documents
Il'chenko, A.A.; Zurabishvili, N.G.; Zhukhovitskiĭ, B.G.; Gorodinskaia, V.S. 1991: Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies) Terapevticheskii Arkhiv 63(2): 21-26Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Prieto Bozano, G.; Larrauri Martínez, J.; Bejarano López, A.; Lorente Miñarro, M.; Carrasco Gandía, S.; Polanco Allué, I. 1993: Colloidal bismuth subcitrate and amoxicillin in the treatment of Helicobacter pylori infection in children Anales Espanoles de Pediatria 38(6): 525-528
Chey, W.D.; Fisher, L.; Elta, G.H.; Barnett, J.L.; Nostrant, T.; DelValle, J.; Hasler, W.L.; Scheiman, J.M. 1997: Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial American Journal of Gastroenterology 92(9): 1483-1486
Duggan, A.; Williamson, R. 1998: Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori Gut 42(4): 596-597
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059
Chen, J.T.; Kurokawa, Y.; Nakayama, K.; Saito, K.; Sakamoto, K.; Fukuda, K.; Hirai, Y.; Hamada, T.; Fujimoto, I.; Yamauchi, K. 1987: The effect of bismuth subnitrate on cisplatin toxicity Nihon Sanka Fujinka Gakkai Zasshi 39(5): 815-822
Karita, M.; Morshed, M.G.; Ouchi, K.; Okita, K. 1994: Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate American Journal of Gastroenterology 89(7): 1032-1035
Morikawa, T.; Kawamura, E. 1989: A method of cisplatin administration with the aid of high-dose bismuth subnitrate, and their pharmacokinetics Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-1): 1094-1098
Gao, W.; Cheng, H.; Hu, F.-l.; Lü, N.-h.; Xie, Y.; Sheng, J.-q.; Xu, J.-m.; Zhang, L.-x.; Zhang, L.; Chen, Y.; Zhang, Z.-y.; Zhang, G.-x.; Cui, M.-h.; Yang, G.-b.; Gao, H.-j.; Yang, L. 2012: Ilaprazole based bismuth-containing quadruple regimen for the first-line treatment of Helicobacter pylori infection: a multicenter, randomized, controlled clinical study Zhonghua Yi Xue Za Zhi 92(30): 2108-2112
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Shimamoto, C.; Tokioka, S.; Hirata, I.; Tani, H.; Ohishi, H.; Katsu, K-ichi. 2002: Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody Hepato-Gastroenterology 49(45): 709-714
Koizumi, W.; Tanabe, S.; Imaizumi, H.; Hibi, K-ichi.; Kida, M.; Ohida, M.; Okayasu, I.; Saigenji, K. 2003: Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection Hepato-Gastroenterology 50(49): 293-296
Lou, J-gan.; Chen, J.; Huang, X-lei.; Zhao, Z-yan. 2007: Changes in the intestinal microflora of children with Helicobacter pylori infection and after Helicobacter pylori eradication therapy Chinese Medical Journal 120(10): 929-931
Kowalski, M. 2001: Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. the detection of H. pylori specific DNA in human coronary atherosclerotic plaque Journal of Physiology and Pharmacology An Official Journal of the Polish Physiological Society 52(1 Suppl 1): 3-31
Henry, A.; Batey, R.G. 1998: Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Australian and New Zealand Journal of Medicine 28(3): 345
1989: Ulcer--campylobacter pylori--bismuth therapy Der Internist 30(2 Suppl Ulkus ): 1-11
Marini, R.P.; Fox, J.G.; Taylor, N.S.; Yan, L.; McColm, A.A.; Williamson, R. 1999: Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets American Journal of Veterinary Research 60(10): 1280-1286
Thong-Ngam, D.; Chayanupatkul, M.; Klaikeaw, N.; Rerknimitr, R.; Mahachai, V. 2009: Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori Journal of the Medical Association of Thailand 92(9): 1207-1212
Muszyński, J.; Biernacka, D.; Bogacka-Zatorska, E.; Stepka, M.; Galczak, A.; Zalewski, L.; Lissowska, K.; Ehrmann, A. 1992: Effect of colloid bismuth treatment on Campylobacter pylori infection of the gastric mucosa and the clinical course of non-ulcer dyspepsia Polski Tygodnik Lekarski 47(3-4): 75-78